Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Ruanne Vanessa Barnabas, M.B.,Ch.B., Ph.D.

Concepts (300)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
HIV Infections1002024167155.400 Why?
Papillomavirus Vaccines1120244913.630 Why?
Anti-HIV Agents33202442553.270 Why?
Papillomavirus Infections18202415873.140 Why?
Uterine Cervical Neoplasms17202320183.040 Why?
South Africa39202417312.390 Why?
Viral Load27202233002.110 Why?
Kenya2720246852.040 Why?
AIDS Serodiagnosis720181841.640 Why?
Sexual Partners1120237281.610 Why?
Family Planning Services820232631.600 Why?
Post-Exposure Prophylaxis420221021.500 Why?
Cost-Benefit Analysis26202253881.440 Why?
Hydroxychloroquine520234121.380 Why?
Community Health Services420206501.350 Why?
Counseling13202215231.270 Why?
Antiviral Agents5202029841.270 Why?
Models, Theoretical13202135871.090 Why?
Models, Economic420227121.080 Why?
HIV-120202369391.020 Why?
Anti-Retroviral Agents12202317141.000 Why?
Heterosexuality620202750.960 Why?
Mass Screening17202352510.930 Why?
CD4 Lymphocyte Count12202225600.900 Why?
Acyclovir220152720.880 Why?
Alphapapillomavirus320222210.870 Why?
Isoniazid320212740.860 Why?
Home Care Services720186080.850 Why?
Herpesvirus 2, Human320151890.850 Why?
Africa South of the Sahara1120207240.820 Why?
Contact Tracing320202730.780 Why?
Continuity of Patient Care3202010490.780 Why?
Herpes Genitalis320141400.770 Why?
Schistosomiasis haematobia12020150.750 Why?
Uganda9202112370.750 Why?
Tuberculosis4202119140.740 Why?
Circumcision, Male620191500.730 Why?
Pharmacies120211500.720 Why?
Schistosomiasis mansoni12020850.700 Why?
Schistosomiasis12019620.690 Why?
Diagnostic Tests, Routine420197820.670 Why?
Human papillomavirus 16420242610.670 Why?
Case Management120202860.640 Why?
Delivery of Health Care9202253190.630 Why?
Antiretroviral Therapy, Highly Active6201818720.620 Why?
Vaginosis, Bacterial120191280.620 Why?
Health Services Needs and Demand3201914110.610 Why?
Infectious Disease Transmission, Vertical5202113200.590 Why?
Immunization Schedule120182210.580 Why?
Female9520243800200.580 Why?
Chemoprevention220183190.580 Why?
Pregnancy Complications, Infectious6202120270.550 Why?
Humans13520247438110.550 Why?
Young Adult322022563920.530 Why?
Disease Transmission, Infectious220185460.530 Why?
Antibiotic Prophylaxis120216380.530 Why?
Precancerous Conditions220239750.520 Why?
Vaccination8202332750.520 Why?
Systems Analysis520231710.510 Why?
Rural Population10202222070.510 Why?
Adult6420232138890.500 Why?
Randomized Controlled Trials as Topic11202499440.500 Why?
Program Evaluation4202124830.490 Why?
Motivation3202119710.480 Why?
Prevalence162023152110.480 Why?
AIDS Vaccines320219380.470 Why?
Virus Shedding320221090.470 Why?
Human papillomavirus 18320241280.460 Why?
Sexually Transmitted Diseases420226230.460 Why?
Antitubercular Agents2202113200.450 Why?
AIDS-Related Opportunistic Infections220216560.450 Why?
Adolescent362023857290.450 Why?
Herpes Zoster120152640.430 Why?
Papillomaviridae4202311190.430 Why?
Costs and Cost Analysis1201816800.430 Why?
Resource Allocation120143410.410 Why?
Health Care Costs5201932070.410 Why?
Male6720233497760.410 Why?
National Health Programs120154450.400 Why?
Incidence162022209480.390 Why?
Epidemiologic Studies120146760.380 Why?
Epidemics120165230.360 Why?
Occupational Exposure1202017870.350 Why?
Patient Selection1202242100.350 Why?
Acquired Immunodeficiency Syndrome2202222320.340 Why?
Prenatal Care4202210920.330 Why?
HIV Seropositivity320239710.310 Why?
Herpes Simplex120114700.310 Why?
Heterocyclic Compounds, 3-Ring220202150.300 Why?
Ambulatory Care Facilities420229340.270 Why?
Double-Blind Method62023120200.260 Why?
Tanzania4202413460.250 Why?
Early Detection of Cancer7202330890.240 Why?
Pandemics7202483850.240 Why?
HIV4202416040.240 Why?
Pregnancy172022291400.220 Why?
Middle Aged3020222132410.220 Why?
Contraceptive Devices, Female12023430.220 Why?
Men's Health22020700.220 Why?
Coitus120231320.210 Why?
Treatment Outcome112021630420.210 Why?
Carcinoma, Squamous Cell1201840330.210 Why?
Homosexuality, Male7202312400.210 Why?
Malaria1201112390.200 Why?
Serologic Tests220223750.190 Why?
Sexual Behavior6202320490.190 Why?
Schistosoma haematobium12020110.190 Why?
Patient Compliance2202326830.180 Why?
Risk Factors152022722520.180 Why?
Marriage120213390.180 Why?
Prospective Studies102023532500.170 Why?
Unsafe Sex120212200.170 Why?
Schistosoma mansoni120201490.170 Why?
Genitalia120191120.170 Why?
Multicenter Studies as Topic2202216760.160 Why?
HIV Seroprevalence12018860.160 Why?
Maternal Welfare120191150.160 Why?
Benzoxazines120203010.160 Why?
Preventive Medicine120202630.160 Why?
Zambia120182610.160 Why?
Syphilis120202270.160 Why?
Markov Chains220209680.160 Why?
RNA, Viral3202229010.160 Why?
Models, Organizational220195740.150 Why?
Endemic Diseases220211820.150 Why?
Trichomonas Vaginitis12017350.150 Why?
House Calls120191620.150 Why?
Mass Vaccination120181050.140 Why?
HIV Integrase Inhibitors120181420.140 Why?
Ascorbic Acid120206500.140 Why?
Postnatal Care120182360.140 Why?
Pregnant Women120215680.140 Why?
Trichomonas vaginalis12017750.140 Why?
Poverty2201926600.140 Why?
Plasma120195750.140 Why?
HIV Seronegativity120172110.140 Why?
Pilot Projects3202083160.140 Why?
World Health Organization2202113170.130 Why?
Primary Prevention2201311670.130 Why?
Community Networks120172030.130 Why?
Saliva120198090.130 Why?
Self Report2202435500.130 Why?
Cohort Studies52022405450.130 Why?
Risk Assessment72021233270.120 Why?
Primary Health Care2202145560.120 Why?
Models, Statistical3201851000.120 Why?
Tuberculosis, Pulmonary120218110.120 Why?
Case-Control Studies32022217330.120 Why?
Self Care120197860.120 Why?
Referral and Consultation3201835300.120 Why?
Family Characteristics2201610000.120 Why?
Directive Counseling120151660.120 Why?
Occupational Health120208080.110 Why?
Quality-Adjusted Life Years2201916830.110 Why?
Prenatal Diagnosis1202012370.110 Why?
Reward120209400.110 Why?
Aged, 80 and over52022577440.110 Why?
Administration, Oral1202139120.110 Why?
Critical Pathways120174760.110 Why?
Cross-Sectional Studies52022250320.110 Why?
Point-of-Care Systems3201711770.110 Why?
Infection Control120209640.110 Why?
Research1202119990.110 Why?
HIV Antibodies1201913220.110 Why?
Coronavirus Infections2202031340.100 Why?
Pneumonia, Viral2202032410.100 Why?
Drug Administration Schedule1202049310.100 Why?
Developing Countries2202128150.100 Why?
Health Plan Implementation120143510.100 Why?
Eligibility Determination120154040.100 Why?
Gender Identity120176860.100 Why?
Health Resources120179120.100 Why?
Social Perception120154250.100 Why?
Child82022776370.100 Why?
Data Collection1202033390.100 Why?
Placebos1201516740.090 Why?
Perception1201711980.090 Why?
Sex Distribution1201522980.090 Why?
Time Factors32020400380.090 Why?
Injections, Subcutaneous220226670.090 Why?
Focus Groups3202413200.090 Why?
Cost of Illness1201918590.090 Why?
Seroepidemiologic Studies220144030.090 Why?
Aged1020221631780.090 Why?
Medication Adherence2201720630.080 Why?
Income1201719130.080 Why?
Health Status1202140310.080 Why?
Qualitative Research3202426820.080 Why?
Oxazines220202980.080 Why?
Age Factors32020183550.080 Why?
Patient Participation1201714570.080 Why?
Chronic Disease2202191390.070 Why?
Health Services Accessibility3201951360.070 Why?
Drug Combinations2202219580.070 Why?
Patient Education as Topic1201622780.070 Why?
Australia1200811670.060 Why?
Disease Progression22022132730.060 Why?
Drug Resistance, Viral220218200.060 Why?
Finland120066020.060 Why?
Survival Analysis12018102510.060 Why?
Vulnerable Populations220206850.060 Why?
Pyridones220207110.060 Why?
Telemedicine2201928740.060 Why?
United States32020698590.060 Why?
Patient Acceptance of Health Care2201530200.060 Why?
Severity of Illness Index12022155260.060 Why?
Virus Replication1201225350.060 Why?
Quality Improvement1201937500.060 Why?
Acetic Acid12023550.060 Why?
Georgia120231870.060 Why?
Postpartum Period2202110860.050 Why?
Entrepreneurship12022240.050 Why?
Lesotho12022700.050 Why?
History, 20th Century2202027360.050 Why?
Depression1202177600.050 Why?
Antibodies, Viral2202431750.050 Why?
Asymptomatic Infections120221280.050 Why?
Condoms120233230.050 Why?
Doxycycline120223260.050 Why?
Zimbabwe120201290.050 Why?
Ukraine120201110.050 Why?
Chlamydia trachomatis120222460.050 Why?
Viral Vaccines120066360.050 Why?
Longitudinal Studies32022139800.050 Why?
Colombia120202580.040 Why?
Depressive Disorder, Major1201746350.040 Why?
Public Sector120212650.040 Why?
Africa, Southern12019570.040 Why?
Dose-Response Relationship, Drug12012109400.040 Why?
Mozambique12019540.040 Why?
Peru120228820.040 Why?
Alkynes120203050.040 Why?
Bisexuality120212690.040 Why?
Follow-Up Studies22017390010.040 Why?
Piperazines2202024870.040 Why?
Netherlands1202321700.040 Why?
Cyclopropanes120204150.040 Why?
Asymptomatic Diseases120215520.040 Why?
Canada1202320640.040 Why?
Washington120183140.040 Why?
Molecular Diagnostic Techniques120226020.040 Why?
Forecasting1200629500.040 Why?
Public Health2202126030.040 Why?
Risk-Taking220139860.040 Why?
DNA, Protozoan120172370.030 Why?
Communicable Disease Control120238560.030 Why?
Antibody Formation1202114020.030 Why?
Retrospective Studies12024774100.030 Why?
Hemorrhagic Fever, Ebola120204260.030 Why?
Population Surveillance1200626140.030 Why?
Specimen Handling120206940.030 Why?
Drug Resistance1202116060.030 Why?
Models, Biological1201195820.030 Why?
Efficiency120184620.030 Why?
Organizational Innovation120185590.030 Why?
Domestic Violence120161760.030 Why?
Kinetics1202264760.030 Why?
Workflow120198470.030 Why?
History, 21st Century1202015320.030 Why?
Pharmaceutical Preparations1202210700.030 Why?
Drug Monitoring120209530.030 Why?
Africa120156720.030 Why?
Americas120131100.030 Why?
Europe1202033360.030 Why?
Early Diagnosis1201811860.030 Why?
Program Development1201913140.030 Why?
Schools1202114320.030 Why?
Polymerase Chain Reaction1202261700.030 Why?
Health Care Surveys1201924530.020 Why?
Health Services Research1201918360.020 Why?
Neoplasms12019216750.020 Why?
Chlamydia Infections120143650.020 Why?
Developmental Disabilities1201814520.020 Why?
Uterine Cervical Dysplasia120143870.020 Why?
ROC Curve1201735270.020 Why?
Clinical Protocols1201514590.020 Why?
Social Stigma120157010.020 Why?
Hyperglycemia1201713730.020 Why?
Mortality1202028620.020 Why?
Interviews as Topic1201525380.020 Why?
Animals120201686600.020 Why?
Health Knowledge, Attitudes, Practice2201339210.020 Why?
Communication1202137480.020 Why?
Ambulatory Care1201827070.020 Why?
Clinical Trials as Topic1202379080.020 Why?
Mental Health1202130120.020 Why?
Pregnancy Complications1202028610.020 Why?
Sensitivity and Specificity12019147140.020 Why?
Attitude of Health Personnel1201838390.010 Why?
Multivariate Analysis12017122430.010 Why?
Predictive Value of Tests12019150670.010 Why?
Blood Glucose1201762590.010 Why?
Practice Guidelines as Topic1202072700.010 Why?
Logistic Models12017134040.010 Why?
Research Design1201759830.010 Why?
Infant12021351220.010 Why?
Computer Simulation1201161880.010 Why?
Child, Preschool12020409640.010 Why?
Hypertension1201784800.010 Why?
Obesity12017127440.010 Why?
Barnabas's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (300)
Explore
_
Co-Authors (14)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.